home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Meetings and Conferences  

BioBusiness Network 2004

  July 01, 2004  
WBR, Hotel President Wilson, Geneva
21-23 September 2004

Key Topics:

*Biogen Idec: Becoming a 21st Century Global Biotech Leader - The Realities Of Integration
*Debate deal valuation trends & their implications on your future strategy
*Hear the inside story on Aventis/Regeneron –the highest up-front Phase I fee ever paid
*Hear how Intercell raised Europe’s largest biotech private equity financing ever
*Pitch 10 of Europe’s leading venture capital funds in our “Venture Capital 2-Minute Pitch Challenge”

Organized by: WBR
Invited Speakers: Key Speakers:

*Bill Rastetter, Executive Chairman, BIOGEN IDEC
*Robert J. Hugin, Senior VP and CFO, CELGENE CORPORATION
*Craig Smith, Chairman, President & CEO, GUILFORD PHARMACEUTICALS
*Spiro Rombotis, CEO, CYCLACEL
*Andy Richards, Biotech entrepreneur

Deadline for Abstracts: N/A
Registration: Please Contact Rachel Bridgman via email or on +44 (0)20 7368 9400.
E-mail: rachel14@wbr.co.uk
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.